[The fate of patients with renovascular hypertension after surgical and drug therapy].
The results of treatment of 328 patients with renovascular hypertension, including 235 cases of surgical correction, are analyzed. Late results (6-month to 14-year follow-up) are examined in 160 surgical cases. The incidence of hypertensive relapses was shown to increase with the duration of follow-up; its major causes were identified. Five-year success rate was estimated at 68%, using actuarial techniques, and five-year postsurgery survival rate was 83.7%. The outcomes of conservative treatment were reviewed in 45 cases followed up for up to 7 years. The results suggest that conservative treatment for renovascular hypertension is not advisable as it aggravates vital prognosis and results in stable loss of working capacity in 60% of the patients, while operations provide an opportunity to maintain working capacity as a long-term perspective in 58% of the patients.
D000293:Adolescent; D000328:Adult; D001807:Blood Vessel Prosthesis; D002648:Child; D004185:Disability Evaluation; D005500:Follow-Up Studies; D006801:Humans; D006977:Hypertension, Renal / Q000601:surgery*; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D008875:Middle Aged; D012077:Renal Artery / Q000601:surgery
Sud'ba bol'nykh renovaskuliarnoĭ gipertonieĭ pri khirurgicheskom i medikamentoznom lechenii.